Key result
Non-cardiovascular comorbidities in heart failure patients are associated with poor prognosis, increased hospitalizations, and higher mortality rates.
Why the study?
With population aging, increasing non-cardiovascular comorbidities in chronic heart failure complicate management and worsen prognosis, requiring comprehensive cardiological expertise.
Non-cardiovascular comorbidities significantly worsen prognosis in heart failure patients, necessitating comprehensive management strategies including targeting diabetes and iron deficiency.
With the aging of the population and improvement of life expectancy of patients with heart disease, there is an increase in non-cardiovascular (CV) comorbidities affecting chronic heart failure (HF) patients. The increased prevalence of different CV and non-CV comorbidities is a rising problem in the management of patients with HF, mostly because these comorbidities may lead to poor prognosis, increase of hospitalizations and mortality rate. Recently, important data from multicenter randomized studies point to diabetes mellitus or iron deficiency as new pharmacological targets, and this highlights the need of broad expertise for the 21st-century cardiologist. The management of HF should take into account non-CV comorbidities. In this review, we discuss novel aspects of non-CV comorbidities in HF patients and emphasize the impact on prognosis.
No takes yet. Share an insight, caveat, or question.
Correale et al. (2021) conducted a review in Heart failure. Non-cardiovascular comorbidities was evaluated on Prognosis, hospitalizations, and mortality rate. Non-cardiovascular comorbidities in heart failure patients are associated with poor prognosis, increased hospitalizations, and higher mortality rates.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: